nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Attenuated RNA virus with improved transcription, replication and/or expression rate; influenza A virus attenuation and IIIV virus, herpes virus, rhinovirus or cytomegalovirus epitope gene insertion for multivalent recombinant vaccine production
|
|
|
1996 |
14 |
9 |
p. 939- 1 p. |
artikel |
2 |
Calendar
|
|
|
1996 |
14 |
9 |
p. 940- 1 p. |
artikel |
3 |
Cell-mediated immune responses to MUC1 fusion protein coupled to mannan
|
Apostolopoulos, Vasso |
|
1996 |
14 |
9 |
p. 930-938 9 p. |
artikel |
4 |
DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost
|
Davis, Heather L. |
|
1996 |
14 |
9 |
p. 910-915 6 p. |
artikel |
5 |
DNA sequence encoding non-structural protein-1 of B19 parvo virus; Escherichia coli transformation with plasmid pQE40 NS-1 and antibody production; application in virus infection diagnosis, prevention and therapy with a DNA probe or recombinant vaccine
|
|
|
1996 |
14 |
9 |
p. 939- 1 p. |
artikel |
6 |
Effective immunization of mice against cutaneous leishmaniasis using an intrinsically adjuvanted synthetic lipopeptide vaccine
|
Frankenburg, Shoshana |
|
1996 |
14 |
9 |
p. 923-929 7 p. |
artikel |
7 |
Immunization against diphtheria with special emphasis on immunization of adults
|
Galazka, Artur M. |
|
1996 |
14 |
9 |
p. 845-857 13 p. |
artikel |
8 |
Immunization with meningococcal class 1 outer membrane protein produced in Bacillus subtilis and reconstituted in the presence of Zwittergent or Triton X-100
|
Idänpään-Heikkilä, Ilona |
|
1996 |
14 |
9 |
p. 886-891 6 p. |
artikel |
9 |
Influence of phospholipid composition on antibody responses to liposome encapsulated protein and peptide antigens
|
Phillips, Nigel C. |
|
1996 |
14 |
9 |
p. 898-904 7 p. |
artikel |
10 |
Medicaments for treating autoimmune or viral diseases; bacterial polyprotein interfering substance-containing drug development for e.g. rheumatoid arthritis and AIDS diagnosis and therapy; diagnostic DNA primer and vaccine production
|
|
|
1996 |
14 |
9 |
p. 939- 1 p. |
artikel |
11 |
Monoclonal antibodies specific for human colon carcinoma; associated antigens; monoclonal antibody production, chimeric antibody engineering and anti-idiotype antibody production for use in cancer therapy and vaccine
|
|
|
1996 |
14 |
9 |
p. 939- 1 p. |
artikel |
12 |
Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A (SpaA) of Streptococcus sobrinus: effects of the Salmonella virulence plasmid on the induction of protective and sustained humoral responses in rats
|
Redman, Tamara K. |
|
1996 |
14 |
9 |
p. 868-878 11 p. |
artikel |
13 |
Poly(DL-lactide-co-glycolide) microspheres as carriers for peptide vaccines
|
Ertl, Hildegund C.J. |
|
1996 |
14 |
9 |
p. 879-885 7 p. |
artikel |
14 |
Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model
|
Devi, Sarvamangala J.N. |
|
1996 |
14 |
9 |
p. 841-844 4 p. |
artikel |
15 |
Protective immunity induced in chicken by a single immunization with Mycoplasma gallisepticum immunostimulating complexes (ISCOMS)
|
Sundquist, B.G. |
|
1996 |
14 |
9 |
p. 892-897 6 p. |
artikel |
16 |
PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice
|
Briles, David E. |
|
1996 |
14 |
9 |
p. 858-867 10 p. |
artikel |
17 |
Responses to primary and a booster dose of acellular, component, and whole-cell pertussis vaccines initiated at 2 months of age
|
Huang, Li-Min |
|
1996 |
14 |
9 |
p. 916-922 7 p. |
artikel |
18 |
The use of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine mixed with diphtheria-tetanus-pertussis vaccine in Gambian infants
|
Mulholland, E.Kim |
|
1996 |
14 |
9 |
p. 905-909 5 p. |
artikel |
19 |
Use of mutant forms of bacterial enterotoxin holotoxin; Escherichia coli heat-labile enterotoxin mutagenesis; adjuvant activity in vaccine for virus infection therapy
|
|
|
1996 |
14 |
9 |
p. 939- 1 p. |
artikel |